Antioxidants block nitrosamine
Webinar: Antioxidants block nitrosamine
Nitrosamines are potential mutagens and need to be controlled in human drug products. Recently, nitrosamine contamination of high-profile drugs has prompted numerous recalls, and increased regulatory assessments for marketed products, as well as for new drug applications. Learn from leading experts how antioxidants in drug formulation can minimize the risk of nitrosamine formation.
Related content
-
-
Specialty excipients
-
Pharma Solutions
Related articles
-
Ask the expert: how can ascorbic acid help mitigate nitrosamine risk in drug products?
Ascorbic acid, and other nitrite scavengers, have been shown to act as functional excipients in drug products that can reduce nitrosamine formation by blocking nitrosation reactions.
-
Nitrite scavengers for nitrosamine mitigation: expert takeaways from dsm-firmenich’s AAPS eChalk Talk
Discover the latest insights on nitrosamine risk mitigation presented by dsm-firmenich during an eChalk Talk hosted by the American Association of Pharmaceutical Scientists (AAPS).
-
World Patient Safety Day 2023
Discover how dsm-firmenich is turning insights into innovation this World Patient Safety Day, from nitrosamine risk mitigation to cannabinoid-based therapeutics.
How can we help you?
-
New product concept
Got a notion for your next project or breakthrough innovation? Let’s put our heads together.
-
Sample request
Don’t just take our word for it. Discover how our solutions can support your product development journey.
-
-
Quick links
Customized blends of functional ingredients in one single, efficient premix.
Streamline your product development process and get to market faster.
Solutions to address consumers' health and lifestyle needs, giving you an edge in the market.
Talking Nutrition, Health & Care
Explore new science, consumer insights, industry news and more in our latest articles.
Discover educational whitepapers, webinars, publications and technical information.
Request samples, place orders and view product documentation.